Abstract 4039
Background
The aim of this study was to assess the prognostic significance of parameters derived from pretreatmentF-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) for patients with nasopharyngeal carcinoma (NPC) received intensity-modulated radiation therapy (IMRT). Furthermore, the functional information provided by PET/CT may offer the feasibility of biological conformality in tumor target delineation and dose planning.
Methods
We retrospectively reviewed 82 NPC patients who underwent pretreatment F-18 FDG PET/CT and received IMRT between 2010 and 2013. Maximum standardized uptake value (SUVmax) and metabolic tumor volume (MTV) of the primary tumor were measured by F-18 FDG PET/CT. MTV might be viewed as a collection of absolute SUV values equal to or greater than a certain threshold on each axial image of PET/CT. The ROC curve was used to determine the appropriate cut-off point of SUVmax and MTV. The prognostic significance of MTV, SUVmax was assessed in the study. Meanwhile, the paper studies the relation between SUVmax, MTV, and primary tumor volume (PTV). Receiver operating characteristic (ROC) analysis was used to determine the optimal MTV cut-off value.
Results
Positive correlations between PTV and MTV, SUVmax and MTV were found. PTV, SUVmax, and MTV were significant predictors of survival. The 3-year progression-free survival (PFS) for SUVmax≤8.20 and SUVmax>8.20 were 91.1% and 73.0% (p = 0.027). With furthermore analysis, patients having tumor with lower MTV had higher 3-year PFS than patients having tumor with higher MTV. The percentage of the MTV5.0 in PTV was 14.66±15.75% (95%CI,11.20-18.13).
Conclusions
Our study indicated that PET/CT-derived parameters, SUVmax and MTV, are very important in assessing prognosis and making radiotherapy planning. Patients having tumor with lower MTV had higher 3-year PFS than patients having tumor with higher MTV. It is necessary to give a more aggressive treatment for patients with higher MTV. The MTV5.0 might be an appropriate quantitative definition of hypoxic sub-volumes for radiotherapy boost to improve the therapeutic effect.
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
4162 - ODM-207 - a novel BET bromodomain inhibitor with antitumor activity in nonclinical models of ER+ breast cancer
Presenter: Anu Moilanen
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3747 - HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch.
Presenter: Roman Dubianski
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4688 - Combination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four Consensus Molecular Subtypes.
Presenter: Pietro Paolo Vitiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
498 - Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Presenter: Xiao Fu
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3731 - Effect of the polymorphism rs2470893 of the CYP1A1 gene on ovarian and endometrial cancer in Mediterranean women
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1215 - Cisplatin in NIPEC or HIPEC?
Presenter: Ivan Alvovsky
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2738 - Matrix metalloproteinase-mediated regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment
Presenter: MARIKO HIRAI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2190 - Trametinib synergizes with dexamethasone in KRAS-mutant myeloma cell lines through modulation of NDRG1 and induction of apoptosis
Presenter: Priya Sriskandarajah
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4482 - Functional inhibition of TGF-_ in colorectal cancer cells and its interaction with AXL receptor
Presenter: Davide Ciardiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
624 - Isoform-specific AKT Inhibition Differentially Affects Cell Functions in Pancreatic Adenocarcinoma
Presenter: Hugo Arasanz
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract